Amanda Mauro, PhD
banner
lamandaa.bsky.social
Amanda Mauro, PhD
@lamandaa.bsky.social
Reposted by Amanda Mauro, PhD
Earlier this year I visited Bexorg to see its brain-in-a-bucket experiments in person. The approach raises many technical and ethical questions which I dug into in my profile of the startup in June. Read more here:
endpoints.news/rebooting-de...
Exclusive: Rebooting dead human brains, a biotech startup seeks to reinvent early drug testing work
Startup Bexorg, led by Zvonimir Vrselja, keeps human brains alive to test drugs. Their BrainEx system sustains brain cells for 24 hours to improve drug development and reduce animal testing.
endpoints.news
October 15, 2025 at 1:25 PM
Reposted by Amanda Mauro, PhD
The second reviews the literature assessing the effect of acute fluctuations in sex hormones on large artery endothelial function, including across the menstrual cycle and the diurnal cycle of testosterone secretion journals.physiology.org/doi/abs/10.1... 3/3
The effect of transient sex hormone fluctuations on endothelial function | American Journal of Physiology-Heart and Circulatory Physiology | American Physiological Society
This review article summarizes the current literature investigating the effects of transient sex hormone fluctuations on large artery endothelial function, primarily concerning the menstrual cycle and the diurnal rhythm of testosterone secretion. Women and men experience acute fluctuations in circulating levels of sex hormones, and there is substantial variability in circulating levels of sex hormones in both sexes. These acute fluctuations in sex hormones generally coincide with alterations in endothelial cell function and in vivo endothelium-dependent vasodilation, and we see that the timing of these acute fluctuations match the timing of cardiovascular events in both women and men. It is important to improve our understanding of how acute fluctuations in sex hormones affect endothelial function in women and men, as clinical cardiovascular complications coincide with these changes. This would allow for the identification of novel therapeutic targets and aid in the prevention and treatment of cardiovascular disease.
journals.physiology.org
June 6, 2025 at 3:19 PM
Reposted by Amanda Mauro, PhD
The first reviews the literature assessing sex-specific mechanisms of how the mineralocorticoid and estrogen receptors contribute to vascular outcomes in aging and obesity www.sciencedirect.com/science/arti... 2/3
Mineralocorticoid and estrogen receptors as sex-dependent modulators of vascular health in aging and obesity
Cardiovascular disease (CVD) is the leading cause of death in both men and women, but there are sex differences in the timing and mechanisms of diseas…
www.sciencedirect.com
June 6, 2025 at 3:19 PM
Reposted by Amanda Mauro, PhD
May 29, 2025 at 8:55 PM